Jonathan Root - Dec 13, 2021 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Director
Signature
Dale Holladay, Attorney in Fact for the Reporting Person
Stock symbol
SPRY
Transactions as of
Dec 13, 2021
Transactions value $
$0
Form type
4
Date filed
12/15/2021, 01:56 PM
Previous filing
Dec 6, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Other -2.07M -100% 0 Dec 13, 2021 Directly owned by USVP XII F1, F2
transaction SPRY Common Stock Other -105K -100% 0 Dec 13, 2021 Directly owned by USVP XII-A F1, F2
holding SPRY Common Stock 95.2K Dec 13, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro-rata, in-kind distribution by U.S. Venture Partners XII, L.P. ("USVP XII") and by U.S. Venture Partners XII-A, L.P. ("USVP XII-A"), without additional consideration, to its partners.
F2 Presidio Management Group XII, L.L.C. (PMG XII), the general partner of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, USVP XII), has sole voting and dispositive power with respect to the shares held by USVP XII. The reporting person is a managing member of PMG XII, and shares voting and dispositive power with respect to the shares held by USVP XII. The reporting person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.